Reduced myeloid-derived suppressor cells in the blood and endometrium is associated with early miscarriage

American Journal of Reproductive Immunology

Volumn 73, Issue 6, 2015, Pages 479-486

  Nair, Rohini R ^a   Sinha, Pratima ^b   Khanna, Anuradha ^c   Singh, Kiran ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

Early miscarriage; Myeloid derived suppressor cells; Pregnancy; Recurrent miscarriage

Indexed keywords

CD11B ANTIGEN; CD33 ANTIGEN; INTERLEUKIN 2; IL2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MENSTRUAL CYCLE; MTT ASSAY; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CLINICAL TRIAL; DECIDUA; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY; T LYMPHOCYTE;

ABORTION, SPONTANEOUS; ADULT; DECIDUA; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; MYELOID CELLS; PREGNANCY; T-LYMPHOCYTES;

EID: 84929276485     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12351     Document Type: Article

References (47)

1. Arck PC, Hecher K: Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013; 19:548-556.
2. Elliot MG, Crespi BJ: Placental invasiveness mediates the evolution of hybrid inviability in mammals. Am Nat 2006; 168:114-120.
3. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
4. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
5. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
6. + cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
7. Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou GX, Luo LH, Luan HB: Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol 2011; 65:503-511.
8. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
9. Kahn DA, Baltimore D: Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A 2010; 107:9299-9304.
10. Williams Z: Inducing tolerance to pregnancy. N Engl J Med 2012; 367:1159-1161.
11. Farquharson RG, Jauniaux E, Exalto N, ESHRE Special Interest Group for Early Pregnancy (SIGEP): Updated and revised nomenclature for description of early pregnancy events. Hum Reprod 2005; 20:3008-3011.
12. van den Boogaard E, Kaandorp SP, Franssen MT, Mol BW, Leschot NJ, Wouters CH, van der Veen F, Korevaar JC, Goddijn M: Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod 2010; 25:1411-1414.
13. Kanellopoulos-Langevin C, Caucheteux SM, Verbeke P, Ojcius DM: Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface. Reprod Biol Endocrinol 2003; 1:121.
14. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
15. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID: The role of T-helper cytokines in human reproduction. Fertil Steril 2000; 73:136-142.
16. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10:347-353.
17. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H: The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007; 67:425; author reply 426.
18. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V: Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-268.
19. Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S: Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 2011; 117:5381-5390.
20. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166:678-689.
21. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 2000; 165:779-785.
22. Sinha P, Clements VK, Ostrand-Rosenberg S: Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol 2005; 174:636-645.
23. + myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 2005; 11:6713-6721.
24. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006; 66:1123-1131.
25. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S: Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179:977-983.
26. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA: Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008; 111:4233-4244.
27. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI: Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791-5802.
28. Sinha P, Parker KH, Horn L, Ostrand-Rosenberg S: Tumor-induced myeloid-derived suppressor cell function is independent of IFN-gamma and IL-4R alpha. Eur J Immunol 2012; 42:2052-2059.
29. Ostrand-Rosenberg S, Sinha P: Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182:4499-4506.
30. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
31. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC: Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553-1560.
32. Mauti LA, Le Bitoux MA, Baumer K, Stehle JC, Golshayan D, Provero P, Stamenkovic I: Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest 2011; 121:2794-2807.
33. Kostlin N, Kugel H, Spring B, Leiber A, Marme A, Henes M, Rieber N, Hartl D, Poets CF, Gille C: Granulocytic myeloid-derived suppressor cells expand in human pregnancy and modulate T- cell responses. Eur J Immunol 2014; 44:2582-2591.
34. Srivastava MK, Bosch JJ, Thompson JA, Ksander BR, Edelman MJ, Ostrand-Rosenberg S: Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells. Cancer Immunol Immunother 2008; 57:1493-1504.
35. Pehlivanoglu B, Balkanci ZD, Ridvanagaoglu AY, Durmazlar N, Ozturk G, Erbas D, Okur H: Impact of stress, gender and menstrual cycle on immune system: possible role of nitric oxide. Arch Physiol Biochem 2001; 109:383-387.
36. Lee S, Kim J, Jang B, Hur S, Jung U, Kil K, Na B, Lee M, Choi Y, Fukui A, Gilman-Sachs A, Kwak-Kim JY: Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women. J Immunol 2010; 185:756-762.
37. Lechner MG, Liebertz DJ, Epstein AL: Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010; 185:2273-2284.
38. Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, Francescato S, Basso G, Zanovello P, Onicescu G, Garrett-Mayer E, Montero AJ, Bronte V, Mandruzzato S: A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011; 118:2254-2265.
39. Mei-Dan E, Fainaru O, Hantisteanu S, Shavit T, Ellenbogen A, Hallak M: Proangiogenic immature myeloid cells populate the human placenta and their presence correlates with placental and birthweight. Am J Obstet Gynecol 2012; 207:e141-e145.
40. Fainaru O, Paz G, Hantisteanu S, Hallak M: Myeloid cell alterations in the mouse placenta precede the onset of labor and delivery. Am J Obstet Gynecol 2014; 210:e71-e77.
41. Shynlova O, Nedd-Roderique T, Li Y, Dorogin A, Nguyen T, Lye SJ: Infiltration of myeloid cells into decidua is a critical early event in the labour cascade and post-partum uterine remodelling. J Cell Mol Med 2013; 17:311-324.
42. Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, Miyawaki T, Saito S: Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J Leukoc Biol 2003; 74:514-522.
43. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007; 67:4507-4513.
44. Hu CE, Gan J, Zhang RD, Cheng YR, Huang GJ: Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand J Gastroenterol 2011; 46:156-164.
45. Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG: Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007; 109:4336-4342.
46. Nausch N, Galani IE, Schlecker E, Cerwenka A: Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells. Blood 2008; 112:4080-4089.
47. Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ: The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod 2010; 16:886-895.